20 May 2013
Keywords: avalon, initiates, myc, usa, pharmaceuticals, initiated, drug
Article | 26 February 2007
The USA's Avalon Pharmaceuticals has initiated a drug discovery program targeting the MYC oncoprotein, one of the most important and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 2007
5 March 2007
17 May 2013
© 2013 thepharmaletter.com